Geron Corporation - Financial and Strategic Analysis Review

Geron Corporation - Financial and Strategic Analysis Review

Geron Corporation - Financial and Strategic Analysis Review

Summary

Geron Corporation (Geron) is a biopharmaceuticals engaged developing new drugs for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure and diabetes. The company is advancing an anti-cancer drug and a cancer vaccine that target the enzyme telomerase through multiple clinical trials. It is also involved in the development of human embryonic stem (hESC) cell-based therapeutics. Its key product candidates include GRNVAC1, GRNVAC2 and GRN163L in oncology which is in ongoing stage of development and GRNIC1, GRNCM1 and GRNOPC1 in treating degenerative diseases which are also in clinical trials.

Global Markets Direct, the leading business information provider, presents an in-depth business, strategic and financial analysis of Geron Corporation. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis and Global Markets Direct’s views on the company.

Scope

-The company’s strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
-The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
-The report contains critical company information – business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
-It provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
-Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Reasons to buy

-A quick “one-stop-shop” to understand the company.
-Enhance business/sales activities by understanding customers’ businesses better.
-Get detailed information and financial & strategic analysis on companies operating in your industry.
-Identify prospective partners and suppliers – with key data on their businesses and locations.
-Capitalize on competitors’ weaknesses and target the market opportunities available to them.
-Compare your company’s financial trends with those of your peers / competitors.
-Scout for potential acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

Table Of Contents
Key Information 1
Key Ratios 1
Share Data 1
Performance Chart 1
Table Of Contents 2
List of Tables 3
List of Figures 3
Key Facts 4
Business Description 4
Major Products and Services 5
Overview 5
History 5
SWOT Analysis Overview 6
Overview 6
Geron Corporation - Strengths 6
Broad Patent Portfolio 6
Patented Technology platforms 6
Strong R&D Activities 6
Geron Corporation - Weaknesses 6
Losses from Operating Activities 6
Geron Corporation - Opportunities 6
FDA Approval for Clinical Trial of GRNOPC1 6
Changing Demographics 6
Geron Corporation - Threats 7
Changing Political Climate in USA 7
Tightening of FDA’s Regulatory Oversight 7
Impact of Financial Crisis 7
Key Competitors 8
Key Employees 8
Key Employee Biographies 9
Company Statement 10
Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Financial Ratios 13
Capital Market Ratios 13
Annual Ratios 13
Interim Ratios 14
Ratio Charts 15
Appendix 16
Methodology 16
Ratio Definitions 16
About Global Markets Direct 19
Contact Us 19
Disclaimer 19
List of Tables
Geron Corporation, Key Facts 1
Geron Corporation, Key Ratios 1
Geron Corporation, Share Data 1
Geron Corporation, Key Facts 4
Major Products and Services 5
Geron Corporation, History 5
Geron Corporation, Key Employees 8
Geron Corporation, Key Employee Biographies 9
Geron Corporation, Subsidiaries 12
Geron Corporation, Ratios based on current share price 13
Geron Corporation, Annual Ratios 13
Geron Corporation, Interim Ratios 14
Currency Codes 16
Capital Market Ratios 16
Equity Ratios 16
Profitability Ratios 17
Cost Ratios 17
Liquidity Ratios 17
Leverage Ratios 18
Efficiency Ratios 18
List of Figures
Geron Corporation, Performance Chart (2004 - 2008) 1
Geron Corporation, Ratio Charts 15